SE9002550D0 - Heparinfragment - Google Patents
HeparinfragmentInfo
- Publication number
- SE9002550D0 SE9002550D0 SE9002550A SE9002550A SE9002550D0 SE 9002550 D0 SE9002550 D0 SE 9002550D0 SE 9002550 A SE9002550 A SE 9002550A SE 9002550 A SE9002550 A SE 9002550A SE 9002550 D0 SE9002550 D0 SE 9002550D0
- Authority
- SE
- Sweden
- Prior art keywords
- heparin
- regardless
- activity
- relates
- bleeding time
- Prior art date
Links
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Materials Engineering (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9002550A SE9002550D0 (sv) | 1990-08-01 | 1990-08-01 | Heparinfragment |
PCT/SE1991/000502 WO1992002232A1 (en) | 1990-08-01 | 1991-07-19 | Heparin fragment showing complement inhibition activity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9002550A SE9002550D0 (sv) | 1990-08-01 | 1990-08-01 | Heparinfragment |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9002550D0 true SE9002550D0 (sv) | 1990-08-01 |
Family
ID=20380076
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9002550A SE9002550D0 (sv) | 1990-08-01 | 1990-08-01 | Heparinfragment |
Country Status (2)
Country | Link |
---|---|
SE (1) | SE9002550D0 (sv) |
WO (1) | WO1992002232A1 (sv) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5583121A (en) * | 1994-01-12 | 1996-12-10 | Michigan State University | Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes |
US6127347A (en) * | 1994-01-12 | 2000-10-03 | Univ Michigan | Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes |
US5763427A (en) * | 1995-03-31 | 1998-06-09 | Hamilton Civic Hospitals Research Development Inc. | Compositions and methods for inhibiting thrombogenesis |
US6001820A (en) * | 1995-03-31 | 1999-12-14 | Hamilton Civic Hospitals Research Development Inc. | Compositions and methods for inhibiting thrombogenesis |
ATE224918T1 (de) * | 1995-03-31 | 2002-10-15 | Hamilton Civic Hospitals Res | Zusammensetzung zur hemmung der thromboseentstehung |
US5744457A (en) * | 1995-03-31 | 1998-04-28 | Hamilton Civic Hospitals Research Development Inc. | Compositions and methods for inhibiting thrombogenesis |
US5767269A (en) * | 1996-10-01 | 1998-06-16 | Hamilton Civic Hospitals Research Development Inc. | Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics |
EP1033375A4 (en) * | 1997-11-20 | 2002-04-24 | Ikuo Yamashina | MODIFICATION OF LOW MOLECULAR MASS HEPARIN AND REMEDY FOR SKIN Ulcer |
US6596705B1 (en) | 1998-02-09 | 2003-07-22 | The Regents Of The University Of California | Inhibition of L-selectin and P-selection mediated binding using heparin |
US8569262B2 (en) | 2007-11-02 | 2013-10-29 | Momenta Pharmaceuticals, Inc. | Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization |
US9351992B2 (en) | 2007-11-02 | 2016-05-31 | Momenta Pharmaceuticals, Inc. | Non-anticoagulant polysaccharide compositions |
US8592393B2 (en) | 2007-11-02 | 2013-11-26 | Momenta Pharmaceuticals, Inc. | Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization |
CA2795360A1 (en) | 2010-04-16 | 2011-10-20 | Momenta Pharmaceuticals, Inc. | Tissue targeting |
EP2582355A2 (en) | 2010-06-17 | 2013-04-24 | Momenta Pharmaceuticals, Inc. | Methods and compositions for promoting hair growth |
WO2013095215A1 (en) | 2011-12-19 | 2013-06-27 | Dilaforette Ab | Low anticoagulant heparins |
LT2794665T (lt) | 2011-12-19 | 2017-12-27 | Dilafor Ab | Neantikoaguliaciniai glikozaminoglikanai, apimantys pasikartojantį disacharido vienetą, ir jų medicininis panaudojimas |
JP2016520613A (ja) | 2013-05-28 | 2016-07-14 | モメンタ ファーマシューティカルズ インコーポレイテッド | 薬学的組成物 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4916219A (en) * | 1985-03-28 | 1990-04-10 | University Of Iowa Research Foundation | Oligosaccharide heparin fragments as inhibitors of complement cascade |
US4847338A (en) * | 1985-03-28 | 1989-07-11 | University Of Iowa Research Foundation | Low molecular weight heparin fragments as inhibitors of complement activation |
-
1990
- 1990-08-01 SE SE9002550A patent/SE9002550D0/sv unknown
-
1991
- 1991-07-19 WO PCT/SE1991/000502 patent/WO1992002232A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1992002232A1 (en) | 1992-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9002550D0 (sv) | Heparinfragment | |
RU93054168A (ru) | Димер молекулярного варианта аро-липопротеина, способ его получения, фармацевтическая композиция на его основе | |
PT88930A (pt) | Processo para a preparacao de novos analogos de nucleosidos e de composicoes farmaceuticas que os contem | |
DE3268075D1 (en) | Preparation for treating outer skin wounds and process for manufacturing said preparation | |
PT82724B (pt) | Processo para a preparacao de derivados de difluoro cetona-peptideos e de uma composicao farmaceutica que os contem | |
IL69930A0 (en) | Oral mopidamol preparations and their production | |
BR9205640A (pt) | Dímero de apolipoproteína ai-milano, composiçao farmacológica, processo de preparaçao do dímero, uso deste na preparaçao de medicamentos e processo para o tratamento de aterosclerose e doenças cardiovasculares | |
UA45942A (uk) | 1,3-оксатіолан, його похідні, спосіб (варіанти) його одержання та фармацевтична композиція | |
DK0396184T3 (da) | Anvendelse af ketoconazol og et retinoid til behandling af acne vulgaris | |
FI821804A0 (fi) | Polysackarider baserade pao nytt anti-tromboticum, foerfarande foer dess framstaellning och farmaceutiska kompositioner | |
NO872675L (no) | Middel for hemning av avstoetning av transplanterte organer | |
SE8505488D0 (sv) | Isosilybinfri silibinin | |
EP0333243A3 (en) | Sulphated k5 antigen and sulphated k5 antigen fragments | |
IL83775A0 (en) | Fumaramide derivatives and pharmaceutical compositions containing them for treating skin diseases | |
ATE187648T1 (de) | Zusammensetzungen enthaltend lipoprotein- associated-coagulation-inhibitor (laci) zur herstellung eines medikaments zur behandlung von akuten oder chronischen enzündungen | |
IT8721115A0 (it) | Fitopreparato per la cura di affezioni cutanee. | |
ATE119781T1 (de) | Antikoagulanszubereitung. | |
ZA875847B (en) | Pharmaceutical compositions for the treatment of occlusive vascular diseases | |
DK277387D0 (da) | Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom | |
EP0317933A3 (en) | Treatment of fibromyalgia | |
SU1169655A1 (ru) | Способ лечени тромбооблитерирующих заболеваний артерий конечностей | |
IT1229271B (it) | Preparazione medicinale di un estratto delle radici di ortica, urtica kiovensis (rogowicz), suo impiego per il trattamento di tumori e processo di preparazione. | |
SU929075A1 (ru) | Способ лечени контрактуры дюпюптрена | |
SE8802193D0 (sv) | Externally applicable, antiviral pharmaceutical composition accumulating in the skin and process for the preparation of the same | |
DZ1366A1 (fr) | Nouveaux dérivés de la méthoxycarbonyl-2 n,n'-di-(triméthoxybenzoyle) pipérazine, ainsi que leur procédé de préparation. |